Literature DB >> 2087291

Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child.

J L Berman1, S Kashii, M S Trachtman, R M Burde.   

Abstract

The authors describe a 10-year-old girl in whom optic neuropathy and central nervous system (CNS) disease developed in association with primary Sjögren's syndrome. There was angiographic evidence of cerebral vasculitis and multiple infarcts present on neuroimaging. Results of parotid biopsy, cerebrospinal fluid, and serologic analyses showed abnormalities that were consistent with the diagnosis of Sjögren's syndrome. Although the patient had optic disc pallor on initial evaluation, her color vision and acuity improved with immunosuppressive therapy, as did her other neurologic symptoms. The authors believe this represents the first reported case of optic neuropathy and CNS disease associated with primary Sjögren's syndrome in the pediatric population. The possibility of improvement in visual function with early institution of immunosuppressive therapy makes prompt diagnosis essential.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087291     DOI: 10.1016/s0161-6420(90)32369-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Sjögren syndrome in a child: favorable response of the arthritis to TNFalpha blockade.

Authors:  F Pessler; B Monash; P Rettig; B Forbes; P A Kreiger; R Q Cron
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 2.  Pediatric stroke.

Authors:  Javier F Cárdenas; Jong M Rho; Adam Kirton
Journal:  Childs Nerv Syst       Date:  2011-02-20       Impact factor: 1.475

3.  Pseudotumor cerebri associated with Sjögren's syndrome.

Authors:  Dinu Stanescu; Bahram Bodaghi; Du Le Thi Huong; Dan Milea; B Goulet-Salmon; Jean-Charles Piette; Phuc LeHoang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-15       Impact factor: 3.117

Review 4.  Unique Aspects of Pediatric Sjögren Disease.

Authors:  Rachel L Randell; Scott M Lieberman
Journal:  Rheum Dis Clin North Am       Date:  2021-08-27       Impact factor: 2.670

5.  Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sjögren's syndrome and normal findings on brain magnetic resonance imaging.

Authors:  C P Chang; Y C Shiau; J J Wang; S T Ho; A Kao
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

Review 6.  Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

7.  Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain--a preliminary report.

Authors:  W S Huang; P Y Chiu; A Kao; C H Tsai; C C Lee
Journal:  Rheumatol Int       Date:  2003-02-18       Impact factor: 2.631

8.  Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma.

Authors:  Michele Colaci; Giulia Cassone; Andreina Manfredi; Marco Sebastiani; Dilia Giuggioli; Clodoveo Ferri
Journal:  Case Rep Neurol Med       Date:  2014-08-05

Review 9.  Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.

Authors:  Gaurav Kumar Mittal; Sumidha Mittal; Harleen Kaur; Shreya Rosa Stephen; Shilpa Sekhar; Sachin Sureshbabu; Pulukool Sandhya
Journal:  Rheumatol Int       Date:  2020-10-11       Impact factor: 2.631

10.  Primary Sjögren syndrome in the paediatric age: a multicentre survey.

Authors:  Rolando Cimaz; Annachiara Casadei; Carlos Rose; Jirina Bartunkova; Anna Sediva; Fernanda Falcini; Paolo Picco; Marco Taglietti; Francesco Zulian; Rebecca Ten Cate; Flavio R Sztajnbok; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Eur J Pediatr       Date:  2003-07-29       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.